http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012153857-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
| filingDate | 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012153857-A |
| titleOfInvention | METHOD FOR CORRECTION OF THROMBOPHILIC HEMOSTASIS DISORDERS DURING PREGNANCY |
| abstract | A method for correcting thrombophilic disorders of hemostasis during pregnancy, including determining indicators of the hemostasis system, indicators of endothelial dysfunction, the presence of genetic forms of thrombophilia and habitual loss of pregnancy syndrome, characterized in that a 1.5-fold increase in fibrinogen in 37-39 weeks of pregnancy is estimated at 1 point, increase of 2 or more times in 34-36 weeks and 9-12 weeks - 2 points, 3 points - up to 8 weeks inclusively and in 19-33 weeks, 4 points - in 13-18 weeks; an increase in the prothrombin index to 125% inclusive at 37-39 weeks is estimated at 1 point, 2 points at the periods of 34-36 and 9-12 weeks, an increase of up to 126% or more up to 8 weeks of pregnancy inclusively from 19-33 weeks - 3 points , 4 points - in the period of 13-18 weeks; a decrease in partially thromboplastin activated time to 21-24 seconds at 37-39 weeks is estimated at 1 point, 2 points at 34-36 and 9-12 weeks, a decrease to 20 seconds or less in the period up to 8 weeks inclusive and at 19-33 weeks - 3 points, 4 points - at 13-18 weeks; decrease in the international normalized ratio to 0.7-0.8 cu in 37-39 weeks of pregnancy they are estimated at 1 point, 2 points at 34-36 and 9-12 weeks, a decrease to 0.6 or less in the period up to 8 weeks inclusively and at 19-33 weeks - 3 points, 4 points - at 13-18 weeks; an increase in the index of thrombodynamic potential by 3-5 cu in 37-39 weeks of pregnancy they are estimated at 1 point, 2 points at 34-36 and 9-12 weeks, 3 points up to 8 weeks inclusive and at 19-33 weeks, an increase of 6 cu and more at 13-18 weeks - 4 points; any increase in soluble complexes of fibrin monomers at 37-39 weeks is estimated at 1 point, 2 points at 34-36 weeks, 3 points at 9-12 weeks and 30-33 weeks, an increase of 2 times or more in the period up to 8 weeks inclusively and at 19-29 weeks - 3 points, 4 points - in the period of 13-18 weeks; l |
| priorityDate | 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.